Dziadzko V, Dziadzko M, Medina-Inojosa JR, et al. Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome. Eur Heart J. 2019;40:2194–202.
Deferm S, Bertrand PB, Verbrugge FH, et al. Atrial functional mitral regurgitation: JACC review topic of the week. J Am Coll Cardiol. 2019;73:2465–76.
Reddy YNV, Noseworthy P, Borlaug BA, et al. Screening for unrecognized HFpEF in atrial fibrillation and for unrecognized atrial fibrillation in HFpEF. JACC Heart Fail. 2024;12:990–8.
Article CAS PubMed Google Scholar
Borlaug BA, Sharma K, Shah SJ, et al. Heart Failure with preserved ejection fraction: JACC scientific statement. J Am Coll Cardiol. 2023;81:1810–34.
Tamargo M, Obokata M, Reddy YNV, et al. Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction. Eur J Heart Fail. 2020;22:489–98.
Adamo M, Chioncel O, Benson L, et al. Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: an analysis from the ESC-HFA Heart Failure Long-Term Registry. Eur J Heart Fail. 2023;25:1061–71.
Kajimoto K, Sato N, Takano T. Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction. Eur J Heart Fail. 2016;18:1051–9.
Bartko PE, Hülsmann M, Hung J, et al. Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction. Eur Heart J. 2020;41:2799–810.
Article PubMed PubMed Central Google Scholar
Bartko PE, Heitzinger G, Pavo N, et al. Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study. BMJ. 2021;373. https://doi.org/10.1136/BMJ.N1421. (Epub ahead of print 30 June 2021).
Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19:1574–85.
Article CAS PubMed Google Scholar
Oikawa M, Yoshihisa A, Sato Y, et al. Prognostic impact of moderate mitral regurgitation on hospitalized heart failure patients with preserved ejection fraction: a report from the JASPER registry. Heart Vessels. 2020;35:1087–94.
Inciardi RM, Rossi A, Bergamini C, et al. Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics. Eur J Heart Fail. 2020;22:499–506.
Mălăescu GG, Mirea O, Capotă R, et al. Left atrial strain determinants during the cardiac phases. JACC Cardiovasc Imaging. 2022;15:381–91.
Zoghbi WA, Levine RA, Flachskampf F, et al. Atrial functional mitral regurgitation: a JACC: cardiovascular imaging expert panel viewpoint. JACC Cardiovasc Imaging. 2022;15:1870–82.
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561–632.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/american heart association joint committee on clinical practice guidelines. Circulation. 2021;143:E72–227.
Spieker M, Sidabras J, Lagarden H, et al. Prevalence and prognostic impact of dynamic atrial functional mitral regurgitation assessed by isometric handgrip exercise. Eur Heart J Cardiovasc Imaging. 2024;25:589–98.
Akashi J, Otsuji Y, Nishimura Y, et al. Updated pathophysiological overview of functional MR (ventricular and atrial). Gen Thorac Cardiovasc Surg. https://doi.org/10.1007/S11748-024-02047-5. (Epub ahead of print 2024).
Naser JA, Alexandrino FB, Harada T, et al. The natural history of atrial functional mitral regurgitation. J Am Coll Cardiol. 2024;83:1495–507.
Dal-Bianco JP, Aikawa E, Bischoff J, et al. Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation. Circulation. 2009;120:334–42.
Article PubMed PubMed Central Google Scholar
Deferm S, Bertrand PB, Verhaert D, et al. Mitral annular dynamics in AF versus sinus rhythm: novel insights into the mechanism of AFMR. JACC Cardiovasc Imaging. 2022;15:1–13.
Kagiyama N, Mondillo S, Yoshida K, et al. Subtypes of atrial functional mitral regurgitation: imaging insights into their mechanisms and therapeutic implications. JACC Cardiovasc Imaging. 2020;13:820–35.
Bartko PE, Dal-Bianco JP, Guerrero JL, et al. Effect of losartan on mitral valve changes after myocardial infarction. J Am Coll Cardiol. 2017;70:1232–44.
Article CAS PubMed PubMed Central Google Scholar
Correale M, Magnesa M, Mazzeo P, et al. Left atrial functional remodeling in patients with chronic heart failure treated with sacubitril/valsartan. J Clin Med. 2023;12. https://doi.org/10.3390/JCM12031086. (Epub ahead of print 1 February 2023).
Ledwidge M, Dodd JD, Ryan F, et al. Effect of sacubitril/valsartan vs valsartan on left atrial volume in patients with pre-heart failure with preserved ejection fraction: the PARABLE randomized clinical trial. JAMA Cardiol. 2023;8:366–75.
Article PubMed PubMed Central Google Scholar
Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol. 2011;58:1474–81.
Carino D, Lapenna E, Ascione G, et al. Is mitral annuloplasty an effective treatment for severe atrial functional mitral regurgitation? J Card Surg. 2021;36:596–602.
Deferm S, Bertrand PB, Verhaert D, et al. Outcome and durability of mitral valve annuloplasty in atrial secondary mitral regurgitation. Heart. 2021;107:1503–9.
Claeys MJ, Debonnaire P, Bracke V, et al. Clinical and hemodynamic effects of percutaneous edge-to-edge mitral valve repair in atrial versus ventricular functional mitral regurgitation. Am J Cardiol. 2021;161:70–5.
PopoloRubbio A, Testa L, Grasso C, et al. Transcatheter edge-to-edge mitral valve repair in atrial functional mitral regurgitation: insights from the multi-center MITRA-TUNE registry. Int J Cardiol. 2022;349:39–45.
Masiero G, Montonati C, Rubbio AP, et al. Impact of transcatheter edge-to-edge mitral valve repair on atrial functional mitral regurgitation from the GIOTTO registry. Am J Cardiol. 2024;211:219–27.
Article CAS PubMed Google Scholar
Doldi P, Stolz L, Orban M, et al. Transcatheter mitral valve repair in patients with atrial functional mitral regurgitation. JACC Cardiovasc Imaging. 2022;15:1843–51.
Alkhouli M, Hahn RT, Petronio AS. Transcatheter edge-to-edge repair for atrial functional mitral regurgitation: effective therapy or elusive target?∗. Cardiovasc Interv. 2022;15:1741–7.
Dhont S, van den Acker G, van Loon T, et al. Mitral regurgitation in heart failure with preserved ejection fraction: the interplay of valve, ventricle, and atrium. Eur J Heart Fail. 2024;26(4):974–83. https://doi.org/10.1002/ejhf.3231.
Comments (0)